Concepedia

Publication | Open Access

High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration

10

Citations

32

References

2016

Year

Abstract

Increasing the dose of bevacizumab in refractory PED may be a possible treatment option.

References

YearCitations

Page 1